AdMeTech 19

The Fourth Global Summit on Precision Diagnosis and Treatment of Prostate Cancer is unique multi-disciplinary forum organized to fill the currently existing gap between the key experts of in vivo imaging; the world authorities in the in vitro fluid- and tissue-based molecular diagnostics, including genomics; and thought leaders in the development of observation strategies (e.g., active surveillance) and novel therapeutic interventions.

With two days of sessions and more than 40 presenters, extensive panel discussions and “brain trust” meeting, this event’s goal is to educate the key healthcare stakeholders on the current “best practices” and needs in screening, diagnosis, and treatment, and develop consensus on the future vision for precision care strategy for its realization.